APA (7th ed.) Citation

Magnus, B., Tomas, A., Anders, A., & Eva, Ö. (2008). CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis). European Journal of Haematology, 80(6), 477. https://doi.org/10.1111/j.1600-0609.2008.01062.x

Chicago Style (17th ed.) Citation

Magnus, Björkholm, Andersson Tomas, Ahlbom Anders, and Ösby Eva. "CNOP (mitoxantrone) Chemotherapy Is Inferior to CHOP (doxorubicin) in the Treatment of Patients with Aggressive Non-Hodgkin Lymphoma (meta-analysis)." European Journal of Haematology 80, no. 6 (2008): 477. https://doi.org/10.1111/j.1600-0609.2008.01062.x.

MLA (9th ed.) Citation

Magnus, Björkholm, et al. "CNOP (mitoxantrone) Chemotherapy Is Inferior to CHOP (doxorubicin) in the Treatment of Patients with Aggressive Non-Hodgkin Lymphoma (meta-analysis)." European Journal of Haematology, vol. 80, no. 6, 2008, p. 477, https://doi.org/10.1111/j.1600-0609.2008.01062.x.